Pro company pages include CSV downloads for statements, ratios, chart data, and transcript indexes.
KOE · KR
High-pressure annealing process equipment supplier for semiconductor manufacturing.
Specialty annealing equipment exposure to advanced logic and memory process flows.
Price
$56600.00
Change
-2800.00 (-4.71%)
Market cap
$4.60T
52w range
$24300–$92000
Exchange
KOE
Country
KR
Jason's Chips
Subscribe or sign in with your Substack email for charts, exports, estimates, transcripts, filings, earnings, and news.
Daily close for HPSP Co., Ltd.
Download statements, ratios, chart data, and transcript indexes.
Revenue, gross profit, R&D, operating income, EBITDA, net income, and EPS.
Cash, receivables, inventory, PP&E, assets, debt, liabilities, and equity.
Operating cash flow, capital expenditures, and free cash flow.
Enterprise value, valuation multiples, returns, yields, and cash conversion.
Margins, liquidity ratios, valuation ratios, leverage, and per-share metrics.
Five years of daily close and volume data powering the company chart.
Available earnings-call transcript dates by fiscal year and quarter.
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-12-31 | $240.17B | $232.27B - $260.36B | $1424.19 | $1344.84 - $1573.94 | $147.63B | $137.64B | $115.76B | $18.02B | 5 rev / 5 EPS |
| 2027-12-31 | $332.84B | $321.89B - $360.83B | $1917.91 | $1835.93 - $2127.58 | $204.59B | $190.75B | $155.88B | $24.98B | 2 rev / 1 EPS |
| 2028-12-31 | $435.86B | $421.53B - $472.51B | $2541.85 | $2433.20 - $2819.73 | $267.92B | $249.80B | $206.60B | $32.71B | 1 rev / 2 EPS |
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $45.82B | $43.37B - $48.55B | $244.00 | $228.20 - $267.79 | $28.17B | $26.26B | $19.82B | $3.44B | 3 rev / 1 EPS |
| 2026-09-30 | $71.08B | $67.70B - $77.08B | $453.00 | $423.66 - $497.17 | $43.69B | $40.74B | $36.80B | $5.33B | 3 rev / 1 EPS |
| 2026-12-31 | $86.40B | $82.10B - $92.88B | $506.00 | $473.23 - $555.34 | $53.11B | $49.52B | $41.11B | $6.48B | 2 rev / 1 EPS |
| 2027-03-31 | $78.05B | $74.16B - $83.90B | $0.00 | $0.00 - $0.00 | $47.98B | $44.73B | $0 | $5.86B | 1 rev / 0 EPS |
| 2027-06-30 | $93.10B | $88.46B - $100.08B | $0.00 | $0.00 - $0.00 | $57.23B | $53.36B | $0 | $6.99B | 2 rev / 0 EPS |
| 2027-09-30 | $73.90B | $70.22B - $79.44B | $0.00 | $0.00 - $0.00 | $45.43B | $42.35B | $0 | $5.55B | 2 rev / 0 EPS |
| 2027-12-31 | $98.55B | $93.64B - $105.94B | $0.00 | $0.00 - $0.00 | $60.58B | $56.48B | $0 | $7.39B | 1 rev / 0 EPS |
No price target summary on file.
No grade actions on file.
| Date | Strong buy | Buy | Hold | Sell | Strong sell |
|---|---|---|---|---|---|
| 2026-06-01 | 2 | 5 | 0 | 0 | 0 |
| 2026-05-01 | 2 | 5 | 0 | 0 | 0 |
| 2026-04-01 | 2 | 6 | 0 | 0 | 0 |
| 2026-03-01 | 2 | 6 | 1 | 0 | 0 |
| 2026-02-01 | 1 | 7 | 1 | 0 | 0 |
| 2026-01-01 | 1 | 7 | 1 | 0 | 0 |
| 2025-12-01 | 1 | 7 | 1 | 0 | 0 |
| 2025-11-01 | 1 | 7 | 1 | 0 | 0 |
| Period | Revenue | Gross profit | Gross margin | R&D | Operating income | EBITDA | Net income | EPS |
|---|---|---|---|---|---|---|---|---|
| FY 2025 | $172.96B | $126.29B | 73.0% | $10.69B | $89.90B | $94.11B | $72.66B | $901.00 |
| FY 2024 | $181.40B | $129.61B | 71.5% | $11.52B | $93.95B | $117.48B | $86.28B | $1056.01 |
| FY 2023 | $179.09B | $117.82B | 65.8% | $4.51B | $95.21B | $105.72B | $80.43B | $990.00 |
| FY 2022 | $159.34B | $110.10B | 69.1% | $5.17B | $85.17B | $88.18B | $66.01B | $813.29 |
| FY 2021 | $91.75B | $61.63B | 67.2% | $4.57B | $45.21B | $47.78B | $35.34B | $447.39 |
| FY 2020 | $61.17B | $41.01B | 67.0% | $4.65B | $24.79B | $24.39B | $17.66B | $223.53 |
| FY 2019 | $25.11B | $14.66B | 58.4% | $2.42B | $9.94B | $10.13B | $8.26B | $34.63 |
| FY 2018 | $2.36B | $517.2M | 21.9% | $1.74B | -$2.93B | -$2.26B | -$2.57B | $-32.48 |
| Period | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|
| FY 2025 | $100.21B | $2.43B | $97.88B |
| FY 2024 | $83.83B | $43.11B | $40.26B |
| FY 2023 | $66.38B | $26.18B | $40.19B |
| FY 2022 | $82.10B | $9.45B | $72.66B |
| FY 2021 | $37.78B | $249.7M | $37.53B |
| FY 2020 | $32.62B | $777.5M | $31.84B |
| FY 2019 | $7.45B | $49.4M | $7.40B |
| FY 2018 | -$6.85B | $16.0M | -$6.87B |
| Period | Cash + ST inv. | Receivables | Inventory | PP&E | Assets | Debt | Net debt | Liabilities | Equity |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | $238.94B | $25.62B | $15.96B | $48.69B | $369.71B | $822.2M | -$93.12B | $61.48B | $308.23B |
| FY 2024 | $189.54B | $16.67B | $23.12B | $50.39B | $319.90B | $1.51B | -$59.78B | $41.99B | $277.91B |
| FY 2023 | $230.40B | $12.25B | $24.22B | $42.16B | $320.69B | $2.24B | -$41.09B | $43.61B | $277.08B |
| FY 2022 | $194.67B | $3.40B | $33.89B | $12.81B | $260.93B | $3.05B | -$126.97B | $65.55B | $195.37B |
| FY 2021 | $54.24B | $6.47B | $17.54B | $3.24B | $91.62B | $2.43B | -$51.80B | $38.87B | $52.75B |
| FY 2020 | $36.44B | $835.8M | $8.47B | $2.45B | $52.71B | $1.29B | -$35.16B | $18.32B | $34.39B |
| FY 2019 | $13.32B | $3.94B | $5.62B | $657.8M | $26.26B | $0 | -$13.32B | $5.96B | $20.30B |
| FY 2018 | $6.06B | $335.7M | $4.78B | $764.6M | $13.25B | $0 | -$5.29B | $1.12B | $12.13B |
| Period | Gross margin | Op margin | Net margin | Current | Quick | ROE | ROIC | EV / sales | EV / EBITDA | FCF yield | R&D / rev. | Cash cycle |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | 73.0% | 52.0% | 42.0% | 4.8x | 4.5x | 23.6% | 22.4% | 15.1x | 27.7x | 3.6% | 6.2% | 163d |
| FY 2024 | 71.5% | 51.8% | 47.6% | 5.8x | 5.2x | 31.0% | 25.4% | 11.4x | 17.6x | 1.9% | 6.4% | 183d |
| FY 2023 | 65.8% | 53.2% | 44.9% | 6.3x | 5.8x | 29.0% | 26.2% | 19.2x | 32.6x | 1.2% | 2.5% | 131d |
| FY 2022 | 69.1% | 53.5% | 41.4% | 3.9x | 3.3x | 33.8% | 32.6% | 6.0x | 10.9x | 6.7% | 3.2% | 237d |
| FY 2021 | 67.2% | 49.3% | 38.5% | 2.4x | 1.9x | 67.0% | 61.2% | 8.7x | 16.8x | 4.4% | 5.0% | 211d |
| FY 2020 | 67.0% | 40.5% | 28.9% | 2.9x | 2.4x | 51.3% | 51.6% | 13.4x | 33.6x | 3.7% | 7.6% | 116d |
| FY 2019 | 58.4% | 39.6% | 32.9% | 4.1x | 3.2x | 40.7% | 37.2% | 33.5x | 83.0x | 0.9% | 9.6% | 218d |
| FY 2018 | 21.9% | -124.1% | -108.6% | 10.3x | 6.0x | -21.2% | -24.2% | 359.3x | -375.1x | -0.8% | 73.6% | 997d |
| Period | Revenue | Gross profit | R&D | Op income | Net income | EPS | FCF | Capex | Cash + ST inv. | Inventory | Assets | Debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | -4.7% | -2.6% | -7.2% | -4.3% | -15.8% | -14.7% | +143.1% | +94.7% | +26.1% | -31.0% | +15.6% | -45.6% |
| FY 2024 | +1.3% | +10.0% | +155.3% | -1.3% | +7.3% | +6.7% | +0.2% | -66.4% | -17.7% | -4.6% | -0.2% | -32.3% |
| FY 2023 | +12.4% | +7.0% | -12.8% | +11.8% | +21.9% | +21.7% | -44.7% | -177.1% | +18.4% | -28.5% | +22.9% | -26.7% |
| FY 2022 | +73.7% | +78.7% | +13.3% | +88.4% | +86.8% | +81.8% | +93.6% | -3684.6% | +258.9% | +93.2% | +184.8% | +25.2% |
| FY 2021 | +50.0% | +50.3% | -1.8% | +82.4% | +100.2% | +100.1% | +17.9% | +67.9% | +48.8% | +107.0% | +73.8% | +89.1% |
| FY 2020 | +143.6% | +179.7% | +92.1% | +149.3% | +113.7% | +545.5% | +330.2% | -1475.4% | +173.5% | +50.6% | +100.7% | 0.0% |
| FY 2019 | +963.1% | +2734.7% | +39.1% | +439.2% | +422.1% | +206.6% | +207.8% | -209.4% | +120.0% | +17.7% | +98.2% | 0.0% |
| FY 2018 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Revenue segmentation data unavailable.
No transcripts on file.
2026-08-19EPS est $244.00